An indicative announcement by Zhejiang Shengda Biopharmaceutical Co., Ltd. on the disclosure of the 2023 plan to issue A-shares to specific targets (revised draft)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.